RSS
left upper corner top right upper corner
side
center
left bottom corner bottom right bottom corner
left upper corner top right upper corner
side
center
left bottom corner bottom right bottom corner
left upper corner top right upper corner
side
From:
Month:
Year:
To:
Month:
Year:
center
left bottom corner bottom right bottom corner
left upper corner top right upper corner

Click live support button to begin chat
left bottom corner bottom right bottom corner
left upper corner
Previous day April, 19 2018 Next day
right upper corner
side

Event Details

Date 2018/04/19
Time 09:00 AM
Recurring
Event status
Handicap access, ADA Contact info: Lee Ann Teshima, 808-586-2695
Title Board of Pharmacy Meeting
Location Queen Liliuokalani Conference Room, King Kalakaua Building, 335 Merchant St, 1st Floor, Honolulu, HI 96813
This event was posted on 04/13/2018 12:45 PM
This event was last updated on 04/13/2018 12:45 PM

 

BOARD OF PHARMACY

Professional and Vocational Licensing Division

Department of Commerce and Consumer Affairs

State of Hawaii

 

AGENDA

 

                                                                Date:      Thursday, April 19, 2018

 

                                                                Time:      9:00 a.m.

 

                                          Place:     Queen Liliuokalani Conference Room, First Floor

                                                                                King Kalakaua Building

                                                                                335 Merchant Street

                                                                                Honolulu, Hawaii 96813

 

1.             Call to Order, Public Notice, Quorum – HRS §92-3 Open Meetings and HAR §16-89-70 Oral Testimony

 

2.             Chair’s Report

a.             Announcements and Introductions

b.             Approval of the Previous Minutes – March 15, 2018 Meeting

 

3.             Executive Officer’s Report

                a.             Conferences/Seminars/Meetings

1)            MPJE Item Development Workshop, March 6-8, 2018 – Deferred from March 15, 2018 meeting - Mr. VandenBussche to report on attendance

2)            NABP Annual Meeting, May 5-8, 2018, Denver, Colorado – Ms. Keefe to report on attendance

b.             2018 Legislation

1)            SB 2247, SD1, HD2 Relating to Opioid Antagonists – Authorizes pharmacists to prescribe, dispense, and provide related education on opioid antagonists to individuals at risk of opioid overdose and to family members and caregivers of individuals at risk of opioid overdose without the need for a written, approved collaborative agreement; subject to certain conditions. Sunsets on 7/1/2021. (SB2247 HD2)

2)            HB 2145, HD1, SD1 Relating to Medication Synchronization - Allows the synchronization of plan participants' medications. Requires plans, policies, contracts, or agreements that are offered by health insurers, mutual benefit societies, and health maintenance organizations and provide prescription drug benefits, to apply prorated daily cost-sharing rates for prescriptions dispensed by network pharmacies for less than a thirty-day supply. Repeals 7/1/2023. Effective 7/1/2050. (SD1)

3)            SB 2298, SD2, HD3 Relating to Healthcare Preceptor Tax Credits –Allows advanced practice registered nurses, physicians, dentists, psychologists, pharmacists, physical therapists, and social workers to receive tax credits for acting as preceptors in volunteer-based supervised clinical training rotations provided to eligible students or trainees that enable the students or trainees to obtain an eligible healthcare professional degree or certificate. Establishes the Preceptor Credit Assurance Committee to issue certificates to volunteer preceptors upon verifying that the volunteer preceptors meet the requirements of the tax credit. (SB2298 HD3)

4)            SB 2774, SD1, HD1 Relating to Insurance – Updates various areas of the State's insurance laws to: adopt the NAIC's Corporate Governance Annual Disclosure Model Act beginning on 1/1/2020; allow the Department of Commerce and Consumer Affairs and the Insurance Commissioner to determine whether a request to add or change a trade name or assumed name satisfies certain requirements; clarify certain provider reimbursement requirements; adopt revisions to the Insurance Holding Company System Regulatory Act beginning on 1/1/2020; provide the Insurance Commissioner with additional regulatory authority to supervise or liquidate a captive insurer; enable the Insurance Division to create stopgap measures, until 12/31/2020, to implement the Network Adequacy Model Act; and make various housekeeping amendments to clarify existing language and avoid ambiguities. (SB2774 HD1)

5)            HB 1602, HD2, SD1 Relating to Opioids - Requires the inclusion of a label warning of the risks of addiction and overdose on the packaging of any opioid drug dispensed by a health care professional or pharmacist. Requires a health care professional or pharmacist to also include the warning in an acknowledgment signed by the patient or person receiving the opioid drug for the patient. Effective 7/1/2050. (SD1)

6)            SB3104, SD2, HD2 – Relating to Pharmacy Benefit Managers - Establishes requirements for pharmacy benefit managers and maximum allowable cost, including the ability of pharmacies to receive comprehensive maximum allowable cost lists and bring complaints within the purview of the Department of Commerce and Consumer Affairs, rather than the Department of Health. Requires pharmacy benefit managers to disclose where an equivalent drug can be obtained at or below the maximum allowable cost when a maximum allowable cost is upheld on appeal. Allows contracting pharmacies to reverse and rebill claims if the pharmacy benefit manager establishes a maximum allowable cost that is denied on appeal and is required to pay the difference to the contracting pharmacies. Preserves the prohibition of a contracting pharmacy from disclosing the maximum allowable cost list and related information to any third party. (SB3104 HD1)

7)            HB 2739, HD1 – Relating to Health - Establishes a regulated process under which an adult resident of the State with a medically confirmed terminal disease and less than six months to live may choose to obtain a prescription for medication to end the patient's life. Imposes criminal sanctions for tampering with a patient's request for a prescription or coercing a patient to request a prescription. (HB2739 HD1)

8)            HCR 145, HD1/SCR 135, SD1 - REQUESTING THE BOARD OF PHARMACY TO CONVENE A WORKING GROUP TO REVIEW THE CURRENT SCOPE OF PRACTICE, LICENSING REQUIREMENTS, AND CONTINUING EDUCATION REQUIREMENTS FOR PHARMACISTS AND CONSIDER WHETHER THE SCOPE OF PRACTICE AND CORRESPONDING LICENSING REQUIREMENTS FOR PHARMACISTS SHOULD BE ENHANCED.

c.             Revisions to Pharmacist’s Corresponding Responsibility Guidance Statement –Discussion of     Revisions

              d.             Pharmacists Continuing Education Audit - Report

 

4.           Correspondence

a.             Inquiry on Validity of Prescription of a Deceased/Retired Provider

 

5.             Chapter 91, HRS - Adjudicatory Matters

                a.             In the Matter of the License to Practice Nursing of Apothecure, Inc PHA-2014-12-L, Transmittal                                     Memorandum filed on March 8, 2018, Hearings Officer’s Findings of Fact, Conclusions of Law                             and  Recommended Order Filed on May 16, 2017, and Board’s Final Order

6.             Applications (The Board may move into Executive Session in accordance with HRS §92-4 and §92-5(a)(1)    and (4) “To consider and evaluate personal information relating to individuals applying for licensure;” and            “To consult with the Board’s attorney on questions and issues pertaining to the Board’s powers, duties,             privileges, immunities, and liabilities;”, Board will vote in Open         Meeting.)

                a.             Ratification Lists

                b.             Applications 

                                1)            Pharmacist

                                i.              Carol A. Zinke

                                ii.             Mark K. Miles                                       

 

7.             Next Meeting:       May 17, 2018

                                              9:00 a.m.

                                              Queen Liliuokalani Conference Room

                                              King Kalakaua Building

                                              335 Merchant Street, First Floor

                                              Honolulu, Hawaii 96813

 

8.             Adjournment

 

Individuals who require special needs accommodations are invited to call Lee Ann Teshima, Executive Officer, at (808) 586-2695 at least 4 working days in advance of the meeting.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Attachment(s):
File
RATIFICATION LIST.docx
iCal printable
center
left bottom corner bottom right bottom corner